Un decano de Harvard cobró 150.000 dólares como perito en las demandas contra Tylenolnews2025-09-24T18:51:33+00:00September 24th, 2025|The New York Times|
F.D.A.’s Approval of a Drug for Autism Upends Review Processnews2025-09-23T23:09:46+00:00September 23rd, 2025|The New York Times|
Harvard Dean Was Paid $150,000 as an Expert Witness in Tylenol Lawsuitsnews2025-09-23T21:57:24+00:00September 23rd, 2025|The New York Times|
4 Autism Experts React to Trump’s Plannews2025-09-23T18:50:52+00:00September 23rd, 2025|The New York Times|
Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisisnews2025-09-23T04:39:03+00:00September 23rd, 2025|The New York Times|
La empresa detrás de Tylenol intenta sortear su crisis más recientenews2025-09-23T04:01:05+00:00September 23rd, 2025|The New York Times|
F.D.A. Reviews Reports of Covid Vaccine Deathsnews2025-09-12T17:21:35+00:00September 12th, 2025|The New York Times|
U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on Chinanews2025-09-10T13:52:52+00:00September 10th, 2025|The New York Times|
How Gen Z Protests Overturned a Government, and a Crackdown on TV Drug Adsnews2025-09-10T10:01:16+00:00September 10th, 2025|The New York Times|
Trump Moves to Crack Down on Drug Advertisingnews2025-09-10T01:35:07+00:00September 10th, 2025|The New York Times|
